• Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of "Moderate Buy" from Analysts

    ソース: Buzz FX / 11 2 2025 01:51:10   America/Chicago


    Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Shares of Sutro Biopharma, Inc.
    Read more...
シェアする